340B Consulting

Our team of 340B Apexus Certified Experts can assist your covered entity with everything from implementation and compliance to revenue optimization. See our detailed services list below.

Interested in receiving quarterly news and updates based on relevant 340B topics? If so, you can subscribe (and see what other newsletters we have) here.

Services Overview

Compliance Services

As HRSA continues to scrutinize the program and increase the number of audits it performs, we can assist you in navigating the compliance requirements. Our services include:

  • Policies and Procedures review
  • Quarterly compliance monitoring
  • Annual compliance audits
  • HRSA audit preparation and on-site assistance
  • Patient definition review
  • Medicaid duplicate discount review
  • Staff education and training
  • Third-party system review and selection
  • New implementation guidance
  • IT data extracts and transfer

Revenue Optimization

We can assist you in making sure that you are receiving the optimal financial benefit from the 340B Program relative to the inherent compliance risks of participating in the program.

We are offering a Complimentary Financial Analysis of your 340B Retail Pharmacy Program. If you would like one of our 340B consultants to analyze your retail program for possible revenue opportunities, feel free to contact us.

340B Implementation Assistance

  • Provider-Based location development
  • Revenue analysis
  • Medicare cost report compilation
  • Contract pharmacy negotiation
  • 340B software selection
  • HRSA registration
  • Program monitoring
CMS Attempting to Clarify Some of the Regulations Around Medicare Bad Debt

CMS Attempting to Clarify Regulations Around Medicare Bad Debt 

Have you recently received Medicare bad debt audit adjustments that you felt were unfair? If so, you are not alone. MACs (Medicare Administrative Contractors) have been tightening their auditing standards and practices surrounding Medicare bad debt listings for years. Regulations have been interpreted and enforced differently by MACs, thus causing inconsistent audit standards. Being held to auditing standards […]

Learn More
CMS 340B Hospital Drug Cost Survey Due May 15, 2020

CMS 340B Hospital Drug Cost Survey Due May 15, 2020

The White House Office of Management and Budget (OMB) approved the Centers for Medicare & Medicaid Services’ (CMS) plan, proposed September 30, 2019, to survey 340B hospitals for their net costs for 340B-purchased drugs billed to Medicare Part B, including sub-340B ceiling price discounts and 340B penny prices. CMS announced the final survey requirement on […]

Learn More
COVID-19 and the Impact on 340B

COVID-19 and the Impact on 340B

This article was originally published on March 25th and was updated on April 23rd. It is being updated as new information becomes available. We wanted to provide updates on the most recent HRSA announcements that could impact your 340B Program during the COVID-19 crisis. 340B Eligibility HRSA recently announced that it “is allowing some entities, […]

Learn More

Connect with our team.

To learn more about our services and areas of expertise, send us a message.